Editorial
doi: 10.1056/NEJMe0801925.
Epub 2008 Mar 31.
ACE inhibitors in cardiovascular disease--unbeatable?
- PMID: 18378521
- DOI: 10.1056/NEJMe0801925
Item in Clipboard
Editorial
ACE inhibitors in cardiovascular disease--unbeatable?
N Engl J Med.
.
No abstract available
Comment in
-
Telmisartan, ramipril, or both in patients at high risk of vascular events.N Engl J Med. 2008 Jul 24;359(4):426-7; author reply 427. N Engl J Med. 2008. PMID: 18655247 No abstract available.
Comment on
-
Telmisartan, ramipril, or both in patients at high risk for vascular events.N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Clinical Trial.
Similar articles
-
Telmisartan, ramipril, or both in patients at high risk of vascular events.N Engl J Med. 2008 Jul 24;359(4):426. doi: 10.1056/NEJMc081065. N Engl J Med. 2008. PMID: 18650521 No abstract available.
-
[What is better here: ACE inhibitor or AT1 blocker?].MMW Fortschr Med. 2008 Apr 17;150(16):16-7. MMW Fortschr Med. 2008. PMID: 18557213 German. No abstract available.
-
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075
-
Lessons learned from the ONTARGET and TRANSCEND trials.Curr Atheroscler Rep. 2009 Sep;11(5):371-6. doi: 10.1007/s11883-009-0056-0. Curr Atheroscler Rep. 2009. PMID: 19664381 Review.
-
Telmisartan prevents cardiovascular events in a broad group of at-risk patients.Expert Opin Pharmacother. 2009 Dec;10(18):3113-7. doi: 10.1517/14656560903449231. Expert Opin Pharmacother. 2009. PMID: 19925045 Review.
Cited by
-
Sociology meets genetics: sociogenetic implications for future management of hypertension and heart failure.Curr Treat Options Cardiovasc Med. 2009 Aug;11(4):305-15. doi: 10.1007/s11936-009-0031-7. Curr Treat Options Cardiovasc Med. 2009. PMID: 19627663
-
Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.J Korean Med Sci. 2019 Nov 25;34(45):e289. doi: 10.3346/jkms.2019.34.e289. J Korean Med Sci. 2019. PMID: 31760711 Free PMC article. Clinical Trial.
-
Comparison of primary care prescriptions for old and very old hypertensive patients.Turk J Med Sci. 2023 Apr;53(2):572-585. doi: 10.55730/1300-0144.5618. Epub 2023 Apr 19. Turk J Med Sci. 2023. PMID: 37476867 Free PMC article.
-
Is the combination of enalapril and losartan irrational?Indian J Pharmacol. 2008 Mar;40(2):91. doi: 10.4103/0253-7613.41047. Indian J Pharmacol. 2008. PMID: 21279175 Free PMC article. No abstract available.
-
Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis.Cureus. 2023 Oct 30;15(10):e47954. doi: 10.7759/cureus.47954. eCollection 2023 Oct. Cureus. 2023. PMID: 38034144 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
